(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.01%) $82.62
(0.99%) $2.05
(-0.53%) $2 345.20
(-0.99%) $27.39
(-0.32%) $958.40
(0.09%) $0.933
(0.14%) $11.00
(0.01%) $0.796
(0.01%) $93.31
-2.67% $ 0.730
Live Chart Being Loaded With Signals
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies...
Stats | |
---|---|
Tagesvolumen | 4 203.00 |
Durchschnittsvolumen | 80 998.00 |
Marktkapitalisierung | 5.81M |
EPS | $0 ( 2024-04-04 ) |
Nächstes Ertragsdatum | ( $0.0100 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.100 |
ATR14 | $0.0300 (4.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Xu Xiaochun | Buy | 4 113 158 | Common Stock |
2024-03-15 | Xu Xiaochun | Sell | 0 | Amendment 4 to 1st Amended & Restated Revolving Credit Agr. |
2023-11-17 | Xu Xiaochun | Sell | 600 000 | Common Stock |
2023-09-28 | Xu Xiaochun | Buy | 654 206 | Common Stock |
2023-09-28 | Xu Xiaochun | Sell | 0 | Amendment 3 to 1st Amended & Restated Revolving Credit Agr. |
INSIDER POWER |
---|
80.48 |
Last 97 transactions |
Buy: 26 026 445 | Sell: 10 013 519 |
Thermogenesis Holdings Korrelation
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Thermogenesis Holdings Finanzdaten
Annual | 2023 |
Umsatz: | $9.45M |
Bruttogewinn: | $1.93M (20.44 %) |
EPS: | $-7.59 |
FY | 2023 |
Umsatz: | $9.45M |
Bruttogewinn: | $1.93M (20.44 %) |
EPS: | $-7.59 |
FY | 2022 |
Umsatz: | $10.48M |
Bruttogewinn: | $2.71M (25.85 %) |
EPS: | $-20.45 |
FY | 2021 |
Umsatz: | $9.29M |
Bruttogewinn: | $3.49M (37.58 %) |
EPS: | $-43.41 |
Financial Reports:
No articles found.
Thermogenesis Holdings
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.